VMAT Reduces Moderate to High Integral Dose When Compared to Conventional IMRT for Treatment of Prostate Cancer
W.J. Lubbe, R. Price, K. Ruth, G. Cherian, A. Kutikov, D. Chen, R. Uzzo, M. Buyyounouski, C. Ma, E. HorwitzVolume:
81
Year:
2011
Language:
english
DOI:
10.1016/j.ijrobp.2011.06.742
File:
PDF, 36 KB
english, 2011